Psoriasis kliniske forsøg i Washington
3 studier for Psoriasis søger deltagere på steder i Washington.
Officiel studietekst (engelsk)
Open Label Study to Investigate the Safety and Efficacy of Ponesimod in Moderate-to-Severe Chronic Plaque Psoriasis
- Vanda Investigational Site, Spokane
RekruttererFase 3
Alder 18 til 65 · Alle køn · Opdateret 22. sep. 2026 · NCT07362017A Study to Investigate the Effectiveness of Tirzepatide (LY3298176) Following Initiation of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Plaque PsO and Obesity or Overweight in Clinical Practice (TOGETHER AMPLIFY-PsO)
- Bellevue Dermatology Clinic, Bellevue
- Dermatology of Seattle, Burien
RekruttererFase 4
Alder 18 og opefter · Alle køn · Opdateret 4. sep. 2026 · NCT06857942A Study to Evaluate the Efficacy, Safety, and Drug Levels of Deucravacitinib (BMS-986165) in Adolescent Participants With Moderate to Severe Plaque Psoriasis
- Frontier Derm Partners, Mill Creek
- Local Institution - 0264, Spokane
RekruttererFase 3
Alder 12 til 17 · Alle køn · Opdateret 3. sep. 2026 · NCT06979453Fra ClinicalTrials.gov, data hentet 3. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.